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Abstract: (1) Background: This study investigated the introduction of pediatric robot-assisted
pyeloplasty in a low-volume centre with reference to open pyeloplasty with regards to operative
times, length of stay (LOS) and outcomes and cost analysis. (2) Methods: Data from 10 consecutive
robot-assisted pyeloplasties was compared retrospectively to an age and weight matched cohort
of open pyeloplasties operated on during two previous years. Operative times were analyzed in
conjunction with LOS, outcomes and cost-analysis from patient records. (3) Results: Operative
times remain longer in robot-assisted pyeloplasties (168 (IQR 68) vs. 141 (IQR 51) min), but patients
are discharged from the hospital earlier and may return to daily activities earlier. In our hospital,
the difference in LOS levels to some degree the cost difference between operations. (4) Conclusions:
Robot-assisted pyeloplasty can be safely and economically introduced and maintained in a
low-volume centre.
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1. Introduction
While dismembered pyeloplasty has long been the standard of operative care for ureteropelvic
junction obstruction, the advent of minimally invasive techniques is gaining merit. Smaller incisions
and a shorter length of hospital stay (LOS) decrease the burden on the families involved. Minimally
invasive approaches include laparoscopic pyeloplasty and robotic pyeloplasty. The learning curves of
each are initially steep, but the long term outcomes seem equal to open procedures [1–3]. Although
robot-assisted surgery offers many benefits over laparoscopy with increased dexterity of surgical
instruments, improved 3D-viewing and optical magnification, one of the main drawbacks are the high
costs associated with it. We sought to analyze the introduction of pediatric robot-assisted pyeloplasty
in a low-volume centre (around 10 cases/year), to assess the viability of a new technique in a teaching
hospital without prior experience in laparoscopic pyeloplasty. We also wanted to clarify the economic
justification in low volumes of such an expensive approach.
2. Materials and Methods
2.1. Training
The robotic surgery program was instigated in pilot form in June 2019 and data was collected
prospectively until November 2020 to evaluate the viability of such a program in a low volume center.
The pediatric urology fellow had no prior laparoscopic pyeloplasty experience, but was very familiar
with open renal surgery. The robotic console training consisted of 20 h of skill acquisition, followed
by standardized training on pigs according to Intuitive Surgical protocols (Intuitive Surgical Inc.,
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Sunnyvale, CA, USA). The fellow also visited the adult urologic clinic to follow robotic pyeloplasties
and a designated adult surgeon was proctoring the first pediatric robotic pyeloplasty at our institute.
2.2. Patients
Indications for pyeloplasty were ureteropelvic junction obstruction detected by progressive
hydronephrosis, worsening renal function or pain. During June 2019–May 2020 all patients over
12 kg or 2 years of age with indications for pyeloplasty were allocated a robotic-assisted operation.
Eight patients presented with intermittent flank pain, 1 had progressive hydronephrosis and 1 had
progressive hydronephrosis with infections. During this period, only one patient underwent open
pyeloplasty. The operative registry at the division of pediatric surgery at the Helsinki University
Central Hospital, University of Helsinki was reviewed for our first 10 consecutive patients operated
for ureteropelvic junction obstruction with robot-assisted mini-invasive pyeloplasty during 2019–2020.
The operative registry was then reviewed for patients who had undergone open pyeloplasty for
ureteropelvic junction obstruction during 2017–2018, from which a cohort was age-matched to define a
control group to the robot-assisted cohort. The patients were not randomized due to the retrospective
nature of the study.
The operative registry was analyzed systematically with regards to sex, age, weight, preoperative
urological measurements (AP-diameter, MAG3-renography), theatre time, operative time, console
time, peri- and postoperative complications, postoperative urological measurements (AP-diameter,
MAG3-renography) and reoperations. Complications were graded according to the Clavien–Dindo
classification system [4].
Follow-up times were from 12 to 18 months postoperatively. Follow-up adherence was 100% for
all patients.
2.3. Surgical Technique Robotic Pyeloplasty
All procedures were performed under general anesthesia with intravenous antimicrobial
prophylaxis (cefuroxime 50 mg/kg). Pneumoperitoneum was achieved through an open technique
infraumbilically. Robotic ports and docking were performed by manufacturer guided protocols. Three
robotic ports were utilized (a 12 mm infraumbilical port and two 8 mm working ports) and one assisting
5 mm port. All robotic approaches were transabdominal. The DaVinci Si robotic surgical platform
(Intuitive Surgical Inc., Sunnyvale, CA, USA.) was utilized for the robotics.
In right sided pyeloplasty, the kidney was approached by detaching the ascending colon.
In left-sided pyeloplasty, a transmesenterial approach was utilized with direct access to the pelviureteric
junction without any further colon mobilization. Stay sutures of 4-0 monofilament thread were
placed in the pelvis and traditional Anderson–Hynes dismembered pyeloplasty was performed, with
pelviureteral anastomosis and pyeloplasty done using 5-0 absorbable monofilament threads. Contrary
to the traditional approach, the pelvic resection was smaller in the robotic group. A double-J stent of
appropriate caliber and length was applied during surgery to be removed six weeks postoperatively.
The transmesenterial opening was closed using the 4-0 monofilament thread and a continuous suture.
Drains were placed to patients with mobilization of the colon and were removed at 24 h postoperatively.
All patients had indwelling catheters for 24 h and were mobilized at own will. Prophylactic peroral
antimicrobial treatment was continued until stent removal at one month postoperatively.
2.4. Surgical Technique Open Pyeloplasty
All open pyeloplasties were performed through an anterior extraperitoneal approach with standard
Anderson–Hynes dismembered technique. Transcutaneous blue-stents were applied, which were
subsequently removed at 1 week postoperatively.
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2.5. Follow-Up
All patients attended postoperative follow-ups. JJ-stents applied during robotic surgery
were removed six weeks postoperatively. A first follow-up appointment took place 3 months
postoperatively with ultrasonography and MAG-3 renography. Clinical procedure included follow-ups
with ultrasonography at 6 and 12 months postoperatively with additional follow-ups based on findings.
The patients in the open group had attended follow-ups at 3 and 12 months with additional follow-ups
based on findings.
2.6. Statistics
Continuous variables are described by median and interquartile ranges (IQR). Categorical variables
are presented as frequencies and proportions. A Wilcoxon test or Mann–Whitney test was used for
differences in medians, chi-squared or Fischer’s exact test was used for categorical variables. p-values
of less than 0.05 were considered statistically significant.
2.7. Ethics and Consent
This study was approved by the Institutional Review Board at the New Children’s Hospital,
Helsinki University Hospital, Helsinki, Finland. All work has been done in accordance with the
Helsinki Declaration.
3. Results
Ten patients underwent robotic pyeloplasty during a nine month period 2019–2020, all of who
were found to have extrinsic obstruction of the ureteropelvic junction. There were no conversions
to open surgery, nor were there any perioperative complications. These patients were compared
to an age- and weight-matched cohort of patients, who had undergone open pyeloplasty during
two previous years at our institute (8.0 vs. 7.9 years and 28.3 vs. 29.5 kg; robotic vs. open cohort,
respectively). The median operating time (from incision to skin closure) in the robotic group was
165 min (IQR 152–222), which was slower than the open pyeloplasty group (141 min (IQR 104–158),
p < 0.05). The median console time was 124 min in the robotic group (IQR 115–170). The median
length of hospital stay was 1.5 days (IQR 1–2) in the robotic pyeloplasty group and 6 days (IQR 4–7)
in the open group (p < 0.05), see Table 1. None of the patients who underwent robotic pyeloplasty
received epidural anesthesia postoperatively, which was in stark contrast to the open group, in which
all but two had postoperative epidural anesthesia. The total amount of oxycodone administered to the
patients during the hospital stay did not differ between groups (p > 0.05).
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Table 1. Comparison of preoperative data, perioperative data and outcomes.
Robotic Pyeloplasty Open Pyeloplasty p-Value
n = 10 n = 10
Preoperative characteristics
Patient age 7.9 8.0 p > 0.05
Patient weight 28.3 29.5 p > 0.05
AP-diameter 28 (IQR 22–36) 21 (IQR 15–28) p > 0.05
DRF 48 (IQR 30–50) 46 (IQR 34–49) p > 0.05
Perioperative data
Operative time minutes 165 (IQR 152–222) 141 (IQR 104–158) p < 0.01
Console times 124 (IQR 115–170) n/a
Length of stay, days 1.5 (IQR 1–2) 6.0 (IQR 4–7) p < 0.01
Opiates mg/kg (Oxycodone, po) 0.15 (IQR 0–0.4) 0.35 (IQR 0.07–0.7) p > 0.05
Postoperative epidural anesthesia 0/10 patients 9/10 patients p < 0.01
Total hospital charges of stay 9213 euros 8962 euros
Outcomes
AP-diameter reduction % at 1 year 67 (IQR 29–74) 36 (IQR 14–42) p > 0.05
DRF 48 (IQR 30–51) 47 (IQR 40–50) p > 0.05
Obstruction relieved in MAG3 9/10 patients 10/10 patients p > 0.05
Symptom alleviation 10/10 patients 10/10 patients p > 0.05
Data presented as medians and per patient unless otherwise stated. AP = Anteroposterior, DRF = differential renal
function, IQR = interquartile range, PO = peroral
In both groups, alleviation of symptoms could be observed in all patients. Improvement in the
degree of hydronephrosis could be detected in ultrasonography in all patients in the open cohort and
in 9/10 in the robotic cohort at a 12 month follow-up. The rate of resolution was slower in the robotic
group, with an average of 8 months to resolution compared to 5 months in the open group, but was not
statistically significant (p > 0.05). MAG3-renographies showed resolution of obstruction in all but one
in the robotic group, which was the same patient, who did not show improvement in hydronephrosis
in ultrasonography. For this patient, a retrograde pyelography was performed, in which no clear
obstruction could be observed. A filled 3F Fogarty embolectomy balloon with a diameter of 5 mm
could easily pass over the ureteropelvic junction, suggesting that at least the anastomosis is patent
(Edwards Lifesciences, Nyon, Switzerland). This patient had diminished function (13%) in the affected
kidney preoperatively and had presented with infections. All patients reported alleviation of flank
pain when that had been the indication for surgery (8/10 patients in the robotic cohort).
Three patients reported of discomfort due to stent related issues, either during micturition or
during sports, which were resolved after stent removal and were deemed Grade 1 complications
according to Clavien–Dindo. None of the patients in either group reported of any incision related
issues. No reoperations were indicated during the study period.
To delineate the financial justification of robotic pyeloplasty in a low volume center, we investigated
the costs related to surgery and hospital stay in our institute. The costs in our hospital for the surgical
procedure itself are not dependent on the length of the procedure, but the costs for anesthesia and
operating times are time dependent variables. For 2019, the cost of the robotic pyeloplasty including
operating theatre, instruments and material was 6398 euros and that of open pyeloplasty 6076 euros.
The total cost for robotic surgery for the operation and subsequent ward convalescence was 9213 euros,
and for a traditional open pyeloplasty 8962 euros, converted to 2019 hospital rates. The difference
in costs did not reach statistical significance (p > 0.1). The prices were revised yearly. The length of
home convalescence was an approximation, but roughly the difference in groups was 4 days (verbal
information and parents). Thus, given the current length of operating times and LOS including home
convalescence, pediatric robotic pyeloplasty was efficient and economically justifiable at our institute.
In the first patients, traditional double-J stents were used, which require an additional procedure for
removal, which accounted for 2573 euros in total. However, we subsequently began to use magnetic
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stents, which avoided the need for anesthetic procedures, thereby limiting costs to only the material
price for the stent as removal was scheduled simultaneously with the outpatient clinic.
4. Discussion
We show here, that the introduction of robot-assisted pyeloplasty to a low-volume centre was
both feasible and economically justifiable. Both short- and mid-term outcomes were comparable to
open surgery, but robotic pyeloplasty eases the burden on the families by a shorter hospital stay and
smaller incisions and lower postoperative pain medication demands.
The robot-assisted pyeloplasty has gained a foothold within pediatric pyeloplasties especially
within the USA. Operative times and outcomes seem comparable to open surgery, but economical
aspects of the expensive robotic system has raised concerns. Seideman estimated that within the USA,
robot-assisted pyeloplasty must be performed around 120 min and length of hospital stay limited to
two days for economic justification [1]. Traditional laparoscopic pyeloplasty does not entail such strict
demands due to cheaper instrumentation, but the learning curve of efficient laparoscopic knot-tying
and suturing is steep. The learning curve for robot-assisted pediatric pyeloplasty has been estimated
to be around 37 cases to achieve established operative times [5]. Sorensen et al. concluded that
the operative time for robotic pyeloplasty time was within 1 SD of average open pyeloplasty after
15–20 cases [6]. Kassite further dissected particularities of the learning curve, and show that clear
transition phases can be detected [7]. Although mastery regarding operative times may be attained
after 16 cases, achieving mastery of a pediatric reconstructive procedure was estimated to require over
41 cases. In a Danish study, Reinhardt showed how robotic surgery could be initiated in low volume
centers with a fellow as the console surgeon [8]. In line with our experience, they showed that start-up
of a robotic program is possible with low volumes. Our volumes are even smaller, but still large
enough to initiate robotic surgery in the light of current evidence. We opted to operate all pyeloplasties
robotically if patients were over 2 years of age or over 12 kg in weight to be able to reach 10 cases
within a reasonable time frame.
Salo and colleagues showed that robotic-assisted pediatric pyeloplasty is safe, with a similar
success rate to open surgery, supporting robotic-assisted pyeloplasty in children [9]. They report a
100% success rate for hydronephrosis and flank pain. Their material is similar to ours, with roughly
the same age and weight patients within the robotic group, but slightly longer operative times and
length of hospital stay.
In our material, console times were two tailed, with issues with threads and stents occurring
in three patients, while the operative times were uniform in the rest of the cases. While operative
times were longer in the robotic group, the length of hospital stay was significantly shorter. The first
patient in the robotic group opted to stay in the hospital for three days because of a long home journey
(300 km), but patients over 20 kg tended to be discharged on the first postoperative day without any
further encouragement within the robotic cohort. The amount of postoperative analgesia was lower
in the robotic group, as none of the patients in this cohort received postoperative epidural analgesia,
although the amount of per-oral oxycodone between groups was similar. The robotic cohort patients
were allowed to return to daycare and school of their own free will without any demand for longer
home convalescence. The open cohort patients were instructed to have a home convalescence of
approximately one week after discharge, depending on circumstances. Taking the operative times,
the length of stay at hospital and at home after discharge into consideration, the economic justification
for robotic assisted surgery seems valid. Furthermore, maintaining robotic pyeloplasty practices with
small volumes once initiated and proven viable seems equally acceptable. Low volumes regarding for
instance nephrectomy are not linked to readmission rates and complication rates [10].
We operated two patients, in whom preoperative differential renal function (DRF) was <15%
and thus had a poorly functioning kidney. After informed consent, the families opted for pyeloplasty
in an attempt to at least postpone a possible nephrectomy. Postoperative renography did not reveal
any significant improvement in DRF, but alleviation of symptoms could be observed by parents.
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One of these patients had preoperative infections and the postoperative renography did not show any
improvement in DRF, in line with findings from Dowling and colleagues [11]. Gnech and colleagues
report that pyeloplasty in poorly functioning kidneys rarely leads to nephrectomy during their mean
follow-up of 91 ± 74 months [12]. Previous reports also support this finding, although in many cases,
a preoperative percutaneous nephrostomy was utilized [13–18].
The introduction of robotic-assisted surgery demands appropriate dry training with dedicated
consoles for technical skill acquisition [19]. We invested time on repetitive console training, both
software based and surgical model training before advancing to proper surgery. The primary robotic
surgeon also had experience of open surgery, with the assistant surgeon being extremely experienced.
Prior to surgery, all steps were discussed with the team and constant evaluation of each step and stage
during surgery was vocalized openly. In addition, procedures were analyzed in detail retrospectively
and dry training was utilized to maintain a visual-proprioceptive memory of technique in-between
robotic surgery.
Our study was not without problems. The number of cases was small and the two groups differed
with regard to the experience level of the surgeon. The process for open surgery with everything
involved has been leaned through many years of experience, while robotic surgery was completely
new to us, encompassing many unforeseen retardations. We were unable to get dependable data on
the home-convalescence as the study was done retrospectively, and the parents were asked for this
data retrospectively in conjunction with the outpatient clinic. The follow-up is relatively short. Värelä
and colleagues show, however, that follow-up beyond 12 months is not necessarily mandatory [20].
Despite these drawbacks, we believe that this pilot study still proves the viability of robotic surgery in
our centre. We were able to utilize the robot from adult surgery without the need for initial acquisition,
which of course have to be considered in the cost analysis in different settings. In a low volume-centre
like ours, investing in a robot initially would naturally have been questionable. The operative process
improved during progression, with subsequent reduction in costs. The average total costs for three
patients, where everything proceeded according to plan was 7068 euros, indicating that through
experience, benefits will likely materialize. There was no statistical difference in console times for
robotic pyeloplasty vs. operation times for open pyeloplasty in our material. This has to be taken into
consideration as epidural anesthesia was administered after the operation for the open pyeloplasty
group, which was not taken into account in the operation times in contrast to the robotic group, where
robotic docking was included in the operation times. Further, open surgery was retroperitoneal, while
robotic surgery was transperitoneal or transmesenterial, which further introduces confounding factors.
The transmesenterial approach appears to lower the risk for bowel disturbances and facilitate early
discharge and fast recovery [21,22].
Our pilot study indicates that robotic pyeloplasty could safely be introduced into a low-volume
center with limited laparoscopic renal surgery without significant financial burden (disregarding robot
acquisition) or a need for long learning curves. The outcomes were similar to previous results and the
burden to families was lower. With advancing experience, faster operative times are to be expected,
further justifying the robotic approach for suitable patients. Training needs to be systematic and
comprehensive for immediate introduction of the robotic system in a low volume center. Advancing
proficiency in robotic surgery will also open new indications for its utilization.
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